|
|
||||||||
Department of Anatomy/Cell Biology, Wayne State University School of Medicine, Detroit, MI 48201
The kinetics of IL-1 (
and ß) production after
Pseudomonas aeruginosa corneal infection was examined in
susceptible (cornea perforates) C57BL/6J (B6) and resistant (cornea
heals) BALB/cByJ (BALB/c) mice. IL-1
and -1ß (mRNA and protein)
were elevated in both mouse strains, and levels peaked at 1 day
postinfection (p.i.). Significantly greater amounts of IL-1 protein
were detected in B6 vs BALB/c mice at 1 and 3 days p.i. At 5 days p.i.,
IL-1
and -1ß (mRNA and protein) remained elevated in B6, but began
to decline in BALB/c mice. To test the significance of elevated IL-1 in
B6 mice, a polyclonal neutralizing Ab against IL-1ß was used to treat
infected B6 mice. A combination of subconjunctival and i.p.
administration of IL-1ß polyclonal Ab significantly reduced corneal
disease. The reduction in disease severity in infected B6 mice was
accompanied by a reduction in corneal polymorphonuclear neutrophil
number, bacterial load, and macrophage inflammatory protein-2 mRNA and
protein levels. These data provide evidence that IL-1 is an important
contributor to P. aeruginosa corneal infection. At least
one mechanism by which prolonged and/or elevated IL-1 expression
contributes to irreversible corneal tissue destruction appears to be by
increasing macrophage inflammatory protein-2 production, resulting in a
prolonged stimulation of polymorphonuclear neutrophil influx into
cornea. In contrast, a timely down-regulation of IL-1 appears
consistent with an inflammatory response that is sufficient to clear
the bacterial infection with less corneal
damage.
This article has been cited by other articles:
![]() |
K. Gentil and E. Pearlman Gamma Interferon and Interleukin-1 Receptor 1 Regulate Neutrophil Recruitment to the Corneal Stroma in a Murine Model of Onchocerca volvulus Keratitis Infect. Immun., April 1, 2009; 77(4): 1606 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Venza, M. Cucinotta, M. Visalli, G. De Grazia, S. Oliva, and D. Teti Pseudomonas aeruginosa Induces Interleukin-8 (IL-8) Gene Expression in Human Conjunctiva through the Recruitment of Both RelA and CCAAT/Enhancer-binding Protein {beta} to the IL-8 Promoter J. Biol. Chem., February 13, 2009; 284(7): 4191 - 4199. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Karicherla and J. A. Hobden Nona-D-Arginine Therapy for Pseudomonas aeruginosa Keratitis Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 256 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Tarabishy, B. Aldabagh, Y. Sun, Y. Imamura, P. K. Mukherjee, J. H. Lass, M. A. Ghannoum, and E. Pearlman MyD88 Regulation of Fusarium Keratitis Is Dependent on TLR4 and IL-1R1 but Not TLR2 J. Immunol., July 1, 2008; 181(1): 593 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. McClellan, Y. Zhang, R. P. Barrett, and L. D. Hazlett Substance P Promotes Susceptibility to Pseudomonas aeruginosa Keratitis in Resistant Mice: Anti-inflammatory Mediators Downregulated Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1502 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Huang, R. Y. Reins, R. L. Gallo, and A. M. McDermott Cathelicidin-Deficient (Cnlp / ) Mice Show Increased Susceptibility to Pseudomonas aeruginosa Keratitis Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4498 - 4508. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Hazlett, Q. Li, J. Liu, S. McClellan, W. Du, and R. P. Barrett NKT Cells Are Critical to Initiate an Inflammatory Response after Pseudomonas aeruginosa Ocular Infection in Susceptible Mice J. Immunol., July 15, 2007; 179(2): 1138 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lin, E. Carlson, E. Diaconu, and E. Pearlman CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis J. Leukoc. Biol., March 1, 2007; 81(3): 786 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Hazlett, S. A. McClellan, R. P. Barrett, J. Liu, Y. Zhang, and S. Lighvani Spantide I Decreases Type I Cytokines, Enhances IL-10, and Reduces Corneal Perforation in Susceptible Mice after Pseudomonas aeruginosa Infection Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 797 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Szliter, S. Lighvani, R. P. Barrett, and L. D. Hazlett Vasoactive Intestinal Peptide Balances Pro- and Anti-Inflammatory Cytokines in the Pseudomonas aeruginosa-Infected Cornea and Protects against Corneal Perforation J. Immunol., January 15, 2007; 178(2): 1105 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Zolfaghar, D. J. Evans, R. Ronaghi, and S. M. J. Fleiszig Type III Secretion-Dependent Modulation of Innate Immunity as One of Multiple Factors Regulated by Pseudomonas aeruginosa RetS Infect. Immun., July 1, 2006; 74(7): 3880 - 3889. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Oka, K Norose, K Matsushima, C Nishigori, and M Herlyn Overexpression of IL-8 in the cornea induces ulcer formation in the SCID mouse Br J Ophthalmol, May 1, 2006; 90(5): 612 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Carlson, J. Drazba, X. Yang, and V. L. Perez Visualization and Characterization of Inflammatory Cell Recruitment and Migration through the Corneal Stroma in Endotoxin-Induced Keratitis Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 241 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. McClellan, X. Huang, R. P. Barrett, S. Lighvani, Y. Zhang, D. Richiert, and L. D. Hazlett Matrix Metalloproteinase-9 Amplifies the Immune Response to Pseudomonas aeruginosa Corneal Infection Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 256 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang, R. P. Barrett, S. A. McClellan, and L. D. Hazlett Silencing Toll-like Receptor-9 in Pseudomonas aeruginosa Keratitis Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4209 - 4216. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sosne, P. L. Christopherson, R. P. Barrett, and R. Fridman Thymosin-{beta}4 Modulates Corneal Matrix Metalloproteinase Levels and Polymorphonuclear Cell Infiltration after Alkali Injury Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2388 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Winstanley, S. B Kaye, T. J Neal, H. J Chilton, S. Miksch, C A. Hart, and and the Microbiology Ophthalmic Group Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis J. Med. Microbiol., June 1, 2005; 54(6): 519 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Power, Y. Peng, E. Maydanski, J. S. Marshall, and T.-J. Lin The Development of Early Host Response to Pseudomonas aeruginosa Lung Infection Is Critically Dependent on Myeloid Differentiation Factor 88 in Mice J. Biol. Chem., November 19, 2004; 279(47): 49315 - 49322. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thakur, R. P. Barrett, J. A. Hobden, and L. D. Hazlett Caspase-1 Inhibitor Reduces Severity of Pseudomonas aeruginosa Keratitis in Mice Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3177 - 3184. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lu, K. Fukuda, K. Seki, Y. Nakamura, N. Kumagai, and T. Nishida Inhibition by Triptolide of IL-1-Induced Collagen Degradation by Corneal Fibroblasts Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5082 - 5088. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang and L. D. Hazlett Analysis of Pseudomonas aeruginosa Corneal Infection Using an Oligonucleotide Microarray Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3409 - 3416. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. McClellan, X. Huang, R. P. Barrett, N. van Rooijen, and L. D. Hazlett Macrophages Restrict Pseudomonas aeruginosa Growth, Regulate Polymorphonuclear Neutrophil Influx, and Balance Pro- and Anti-Inflammatory Cytokines in BALB/c Mice J. Immunol., May 15, 2003; 170(10): 5219 - 5227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Xue, D. Wakefield, M. D. P. Willcox, A. R. Lloyd, N. Di Girolamo, N. Cole, and A. Thakur Regulation of MMPs and TIMPs by IL-1{beta} during Corneal Ulceration and Infection Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2020 - 2025. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cole, M. Krockenberger, F. Stapleton, S. Khan, E. Hume, A. J. Husband, and M. Willcox Experimental Pseudomonas aeruginosa Keratitis in Interleukin-10 Gene Knockout Mice Infect. Immun., March 1, 2003; 71(3): 1328 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-J. Lin, R. Garduno, R. T. M. Boudreau, and A. C. Issekutz Pseudomonas aeruginosa Activates Human Mast Cells to Induce Neutrophil Transendothelial Migration Via Mast Cell-Derived IL-1{alpha} and {beta} J. Immunol., October 15, 2002; 169(8): 4522 - 4530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Gregory, A. C. Repp, A. M. Holhbaum, R. R. Saff, A. Marshak-Rothstein, and B. R. Ksander Membrane Fas Ligand Activates Innate Immunity and Terminates Ocular Immune Privilege J. Immunol., September 1, 2002; 169(5): 2727 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Jett and M. S. Gilmore Internalization of Staphylococcus aureus by Human Corneal Epithelial Cells: Role of Bacterial Fibronectin-Binding Protein and Host Cell Factors Infect. Immun., August 1, 2002; 70(8): 4697 - 4700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khatri, J. H. Lass, F. P. Heinzel, W. M. Petroll, J. Gomez, E. Diaconu, C. M. Kalsow, and E. Pearlman Regulation of Endotoxin-Induced Keratitis by PECAM-1, MIP-2, and Toll-like Receptor 4 Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2278 - 2284. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang, S. A. McClellan, R. P. Barrett, and L. D. Hazlett IL-18 Contributes to Host Resistance Against Infection with Pseudomonas aeruginosa Through Induction of IFN-{gamma} Production J. Immunol., June 1, 2002; 168(11): 5756 - 5763. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Pillar and J. A. Hobden Pseudomonas aeruginosa Exotoxin A and Keratitis in Mice Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1437 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thakur, M. Xue, F. Stapleton, A. R. Lloyd, D. Wakefield, and M. D. P. Willcox Balance of Pro- and Anti-Inflammatory Cytokines Correlates with Outcome of Acute Experimental Pseudomonas aeruginosa Keratitis Infect. Immun., April 1, 2002; 70(4): 2187 - 2197. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Hazlett, X. L. Rudner, S. A. McClellan, R. P. Barrett, and S. Lighvani Role of IL-12 and IFN-{gamma} in Pseudomonas aeruginosa Corneal Infection Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 419 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Hazlett, S. A. McClellan, X. L. Rudner, and R. P. Barrett The Role of Langerhans Cells in Pseudomonas aeruginosa Infection Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 189 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kernacki, R. P Barrett, S. McClellan, and L. D. Hazlett MIP-1{alpha} regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection J. Leukoc. Biol., December 1, 2001; 70(6): 911 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Matzer, T. Baumann, N. W. Lukacs, M. Rollinghoff, and H. U. Beuscher Constitutive Expression of Macrophage-Inflammatory Protein 2 (MIP-2) mRNA in Bone Marrow Gives Rise to Peripheral Neutrophils with Preformed MIP-2 Protein J. Immunol., October 15, 2001; 167(8): 4635 - 4643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hurt, S. Apte, H. Leher, K. Howard, J. Niederkorn, and H. Alizadeh Exacerbation of Acanthamoeba Keratitis in Animals Treated with Anti-Macrophage Inflammatory Protein 2 or Antineutrophil Antibodies Infect. Immun., May 1, 2001; 69(5): 2988 - 2995. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thakur, J. Kyd, M. Xue, M. D. P. Willcox, and A. Cripps Effector Mechanisms of Protection against Pseudomonas aeruginosa Keratitis in Immunized Rats Infect. Immun., May 1, 2001; 69(5): 3295 - 3304. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kernacki, R. P. Barrett, S. A. McClellan, and L. D. Hazlett Aging and PMN Response to P. aeruginosa Infection Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3019 - 3025. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |